Drug Pricing Reform Gathers Steam (Part 2)
FDA Law Blog
SEPTEMBER 14, 2021
This bill, which addresses numerous areas of the economy, public health, and government regulation, includes Subtitle E, Drug Pricing. PART 1: MAXIMUM FAIR PRICE PAYMENT LIMITATION UNDER MEDICARE PARTS B AND D AND THE COMMERCIAL INSURANCE MARKET. Subtitle E is a slightly modified version of H.R. 3, the Elijah E. 8126 with a lower MFP.
Let's personalize your content